Application of modified transperineal template-guided prostate biopsy in the diagnosis of prostate cancer / 中华泌尿外科杂志

ABSTRACT

Objective To investigate the clinical value of modified transperineal template-guided prostate biopsy (mTTPB) in the detection of prostate cancer.Methods A total of 217 patients were enrolled in this study.All the patients were randomly divided into 2 groups.The control group (n =112)underwent transperineal template-guided prostate biopsy (TTPB) which was traditional transperineal template-guided 11-region biopsy.On the basis of the control group,the apex of prostate was divided into four areas for biopsy in the observation group (mTTPB).The positive rate of apex and the incidence of complications were analyzed.The prostatic specimens from the radical prostatectomy underwent whole mount sections examination.The prostate biopsy results were compared with the postoperative pathological results.Results The average age of the control group and the observation group were (68.5 ± 7.9) years and (67.3 ± 8.5) years,PSA were (31.2 ± 18.9) ng/ml and (29.7 ± 19.5) ng/ml,prostate volume were (44.6 ± 15.2) ml and (41.3 ± 17.3) ml,respectively.In the control group,the positive rates of prostate cancer in 1-10 region were 24.1％ (27/112),27.7％ (31/112),23.2％ (26/112),28.6％ (32/112),26.8％ (30/112),25.0％ (28/112),26.8％ (30/112),19.6％ (22/112),25.9％ (29/112),25.0％ (28/112),respectively,with an average of 25.3％.In the observation group,the positive rates in 1-10 region were 27.6％ (29/105),28.6％ (30/105),22.9％ (24/105),26.7％ (28/105),25.7％ (27/105),24.8％ (26/105),27.6％ (29/105),21.9％ (23/105),27.6％ (29/105),26.7％ (28/105),respectively,with an average of 26.0％.There was no statistical difference between the two groups (P =0.904).The positive rate of apical prostate cancer in the control group and observation group was 37.5％ (42/112) and 44.8％ (47/105),respectively,and there was no statistical difference between the two groups (P =0.277).Patients were grouped according to PSA ＞ 20 ng/ml and PSA ≤ 20 ng/ml.When PSA ＞ 20 ng/ml,the positive rate of apex was 58.6％ (34/58) and 56.6％ (30/53)respectively in the control group and the observation group,and there was no statistical difference between the two groups (P =0.830).When PSA≤20 ng/ml,the positive rate of apex was 14.8％ (8/54) in the control group and 32.7％ (17/52) in the observation group,with statistically significant differences (P =0.030).Before radical prostatectomy,12 cases (57.1％) in the control group and 19 cases (73.1％) in the observation group showed apical invasion by biopsy.Results of whole mount sections examination in the control group showed that there were 19 cases (90.5％) with apical invasion,which was statistically different from that before surgery (P =0.035).The results of whole mount sections examination in the observation group showed that there were 23 cases (88.5％) with apex invasion,which had no statistical difference compared with that before surgery (P =0.291).There were no significant differences in the incidence of hematuria,fever,urinary retention and perineal discomfort between the observation group and the control group (all P ＞ 0.05).Conclusions mTTPB can significantly improve the detection rate of apical prostate cancer without increasing the incidence of complications,especially for patients with PSA≤20 ng/ml.Hence is safe and efficacious.